Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Gregg Stone Added: 1 year ago
ESC 2023 — Dr Gregg Stone (Icahn School of Medicine at Mount Sinai, US) shares the findings from a real-time updated network meta-analysis comparing OCT, IVUS and Angiography guidance in percutaneous coronary intervention (PCI) procedures. The OCTOBER and ILUMIEN IV randomised trials both studied OCT-guided versus angiography-guided PCI. This analysis compared the overall effects of… View more
Author(s): Byeong-Keuk Kim Added: 6 months ago
ESC Congress 24 — OCCUPI trial finds OCT-guided PCI more effective than angiography-guided PCI in reducing heart-related events.We are joined onsite at ESC 24 by Dr Kim Byeoung-Keuk (Yonsei University College of Medicine, Seoul, SK) to discuss the results of the OCCUPI trial (NCT03625908), which aims to evaluate the clinical benefits of optical coherence tomography (OCT)-guided percutaneous… View more
Research Area(s) / Expertise: Job title: Professor of Medicine / Chief, Division of Clinical Pharmacology / Chief, Division of Cardiology
Manesh Patel is the Chief of the Division of Cardiology and the Division of Clinical Pharmacology. His clinical interests include diagnostic and interventional coronary angiography, peripheral angiography and endovascular intervention. His is involved in several clinical trials involving patients with cardiovascular disease and in cardiac imaging. He is also the Chair of the American College of… View more
Research Area(s) / Expertise: Job title: Interventional Cardiologist
DrSuzanne Baron is anInterventional Cardiologist atMassachusetts General Hospital, Boston, US. Shereceived her BA from Harvard University, her MD from Yale School of Medicine and her MSc from Harvard School of Public Health. Dr Baron is involved in research involving the effects of cardiovascular devices on healthcare costs and patient-reported outcomes and she has published on these topics in… View more
Author(s): Ziad A Ali Added: 1 year ago
ESC 2023 — Dr Ziad Ali (DeMatteis St Francis, US) joins us to discuss the findings from the ILUMIEN IV clinical trial (NCT03507777). ILUMIEN IV (Abbott Medical Devices)is a prospective, single-blind clinical trial aiming to compare optical coherence tomography (OCT) to an angiography-guided stent implantation strategy. The trial investigated which method achieved a larger post-percutaneous… View more
Author(s): Joo-Yong Hahn Added: 2 years ago
ACC.23/WCC - Principal investigator, Dr Joo-Yong Hahn (Samsung Medical Center, KR) joins us to discuss the findings of the RENOVATE-COMPLEX-PCI late-breaking trial (Samsung Medical Center). The investigators compared clinical outcomes between intravascular imaging guided (IVUS) versus angiography guided (OCT) percutaneous coronary intervention (PCI) in 1639 patients with complex lesions … View more
Author(s): Ankur Kalra , Sukhjinder Nijjer Added: 1 year ago
In this week's Parallax, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.Drs Kalra and Nijjer share their… View more
Author(s): Ankur Kalra , Sukhjinder Nijjer Added: 1 year ago
In this week's Parallax podcast, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.Drs Kalra and Nijjer share… View more
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 1 year ago
What is hot at ESC 2023? In this episode of View of the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) preview the hot line and late-breaking data presented at ESC Congress 2023.With their dynamic analysis, they place these highly anticipated trials within a context, highlighting the real-world implications tied to the data releases. Top… View more